N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: A double-blind, randomized, placebo-controlled trial argeting negative symptoms
The SUMMIT trial, involving 731 individuals with HFpEF and obesity followed for a median of 104 weeks, revealed a 38% decrease in the composite endpoint of cardiovascular mortality or heart-failure deterioration events (HR: 0.62, 95%CI: 0.41-0.95, P = 0.026), driven primarily by fewer worsening heart-failure events (8.0% vs
There is evidence for benefits of treatment with acetyl-l-carnitine in conditions such as neuropathy, depression, neurodegenerative disorders, and others [5, 6]
81 PalR.HedauN.KantL.PattanayakA
The seminal work by Nenkov et al
HUBERMAN: So the fact that there is a peptide in our gut that can be involved in tissue turnover and tissue turnover is equivalent to tissue repair is not all that surprising